New name, same level of support.
Starting June 3, 2024, Takeda’s Hematology Support Center (HSC) will become Takeda Patient Support. Patients enrolled in HSC will automatically be enrolled into Takeda Patient Support.
Intended for US Audiences Only
Frequently Asked Questions
Find downloadable forms and online resources on benefits verification, prior authorizations, and appeals.
PA criteria vary from plan to plan; however, the following criteria are commonly found across top payer types and may be required for hematology treatments. These criteria should be considered when drafting a PA request form:
Use this checklist when preparing prior authorization and reauthorization paperwork.
Most products will require re-authorization of an approved PA. Information for a re-authorization should include:
This guide offers information to help you navigate and respond to appeals and denials for Takeda hematology product coverage.
A PA request may not always be approved. A common reason for PA denial is incomplete information. It is crucial for the physician and specialty pharmacy completing the PA request to include:
When a PA request is denied, an appeal must be submitted in the time frame specified by the patient's insurance. It will need to include additional support for why the medication is clinically necessary for the patient.
Use this checklist to help you prepare an appeals letter and
The LMN/SMN is the prescribing physician's opportunity to present all of the rationale for why a certain Takeda hematology product is clinically necessary for the patient. It is important to note that LMN/SMNs should be:
HSC provides sample letters of Medical Necessity for specific Takeda hematology therapies. These are for reference only. You can find them by visiting the Product Information and Coding section.
PAMs are experts specially trained to help your patients who are enrolled in HSC address potential access challenges with their prescribed Takeda hematology treatment. They can also provide your office with insurance and access education.
Fill out your contact information below to request support from a PAM in your area. All fields are required.
A PAM in your area will be contacting you soon.
*PAMs were previously named Reimbursement and Access Managers (RAMs).
Hematology Support Center (HSC)
HSC is not a pharmacy, but works with specialty pharmacies to coordinate handling, storage, and distribution requirements for your patient's prescribed Takeda hematology treatment.
HSC provides product information, coding, resources, and more for Takeda hematology products. You can find it all here.
You can find information about the PA process and how HSC may help here.
In addition, HSC Patient Access Managers (PAMs) are experts specially trained to help your patients address potential access challenges with their prescribed Takeda hematology treatment. They can also provide your office with insurance and access education. Find out how to request assistance from a PAM near you here.
You can find information about the appeals process and how HSC may help here.
In addition, HSC Patient Access Managers (PAMs) are insurance experts trained to help your patients address potential access challenges with their prescribed Takeda hematology treatment. They also work one-on-one with your office by providing insurance and access information and tools when barriers to treatment arise. Find out how to request assistance from a PAM near you here.
An LMN/SMN is a critical component of appealing a coverage denial. The LMN/SMN is the prescribing physician's opportunity to present all of the rationale for why a certain Takeda hematology product is clinically necessary for your patient.
HSC provides sample Letters of Medical Necessity for specific Takeda hematology therapies. You can find them by visiting the Product Information and Coding section.
